← FDA Drug Approvals (Drugs@FDA)

BEXAROTENE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: AMNEAL PHARMS NY · Approved 2018-09-04

Drug application

FDA Application #

ANDA210105

Application type

Abbreviated New Drug Application (Generic)

Brand name

BEXAROTENE

Generic name

BEXAROTENE

Active ingredients

BEXAROTENE

Dosage form

CAPSULE

Route

ORAL

Marketing status

Prescription

Sponsor

AMNEAL PHARMS NY

Manufacturer

Amneal Pharmaceuticals NY LLC

First approval

2018-09-04

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown